• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

3-Bromopyruvic acid

CAS No. 1113-59-3

3-Bromopyruvic acid ( Bromopyruvic acid;Hexokinase II Inhibitor II 3-BP )

产品货号. M20515 CAS No. 1113-59-3

3-Bromopyruvic acid is a hexokinase II inhibitor with Ki of 2.4 mM for glycolysis/hexokinase inhibition. It is inhibitor of tumour cell energy metabolism and chemopotentiator of platinum drugs.

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
500MG ¥332 有现货
1G ¥389 有现货

生物学信息

  • 产品名称
    3-Bromopyruvic acid
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    3-Bromopyruvic acid is a hexokinase II inhibitor with Ki of 2.4 mM for glycolysis/hexokinase inhibition. It is inhibitor of tumour cell energy metabolism and chemopotentiator of platinum drugs.
  • 产品描述
    3-Bromopyruvic acid is a hexokinase II inhibitor with Ki of 2.4 mM for glycolysis/hexokinase inhibition. It is inhibitor of tumour cell energy metabolism and chemopotentiator of platinum drugs.
  • 同义词
    Bromopyruvic acid;Hexokinase II Inhibitor II 3-BP
  • 通路
    Others
  • 靶点
    Other Targets
  • 受体
    hexokinase II
  • 研究领域
    Cancer
  • 适应症
    antineoplastic

化学信息

  • CAS Number
    1113-59-3
  • 分子量
    166.96
  • 分子式
    C3H3BrO3
  • 纯度
    >98% (HPLC)
  • 溶解度
    H2O:32 mg/mL (191.66 mM)
  • SMILES
    OC(=O)C(=O)CBr
  • 化学全称
    ——

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1.Leng X Peng J Yu X et al. 3-Bromopyruvic Acid A Hexokinase II Inhibitor is an Effective Antitumor Agent on the Hepatoma Cells : in vitro and in vivo Findings[J]. Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents) 2014 14(5):-.
产品手册
关联产品
  • H2DCFDA

    H2DCFDA is a cell-permeable probe. Which is used to detect intracellular reactive oxygen species (ROS).

  • Luteolin-7-O-alpha-L...

    Reference standards.

  • N-Boc-Phe-Leu-Phe-Le...

    N-Boc-Phe-Leu-Phe-Leu-Phe (Boc-FLFLF) is a formyl peptide receptor 1 (FPR1) antagonist, which increases pain effects and inhibits antinociceptive activity of annexin. Boc-Phe-Leu-Phe-Leu-Phe is used extensively in FPR research.